Lucile Massenet-Regad

Lucile Massenet-Regad

Auto-generated profile, based on publicly available information

Lucile Massenet-Regad

Université Paris Cité, INSERM U976 HIPI, Paris, F-75010, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
FNFloriane Noël
Floriane Noël
LMLucile Massenet-Regad
Lucile Massenet-Regad
ICIrit Carmi-Levy
Irit Carmi-Levy
ACAntonio Cappuccio
Antonio Cappuccio
MGMaximilien Grandclaudon
Maximilien Grandclaudon
VSVassili Soumelis
Vassili Soumelis
Cell-to-cell communication can be inferred from ligand–receptor expression in cell transcriptomic datasets. However, important challenges remain: global integration of cell-to-cell communication; biological interpretation; and application to individual cell population transcriptomic profiles. We develop ICELLNET, a transcriptomic-based framework integrating: 1) an original expert-curated database of ligand–receptor interactions accounting for multiple subunits expression; 2) quantification of communication scores; 3) the possibility to connect a cell population of interest with 31 reference human cell types; and 4) three visualization modes to facilitate biological interpretation. We apply ICELLNET to three datasets generated through RNA-seq, single-cell RNA-seq, and microarray. ICELLNET reveals autocrine IL-10 control of human dendritic cell communication with up to 12 cell types. Four of them (T cells, keratinocytes, neutrophils, pDC) are further tested and experimentally validated. In summary, ICELLNET is a global, versatile, biologically validated, and easy-to-use framework to dissect cell communication from individual or multiple cell-based transcriptomic profiles.

10 May 2021 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MSMelissa Saichi
Melissa Saichi
MLMaha Zohra Ladjemi
Maha Zohra Ladjemi
SKSarantis Korniotis
Sarantis Korniotis
CRChristophe Rousseau
Christophe Rousseau
ZHZakaria Ait Hamou
Zakaria Ait Hamou
VSVassili Soumelis
Vassili Soumelis

26 July 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
PTPierre TONNERRE
Pierre TONNERRE
DWDavid Wolski
David Wolski
SSSonu Subudhi
Sonu Subudhi
JAJihad Aljabban
Jihad Aljabban
RHRuben C. Hoogeveen
Ruben C. Hoogeveen
GLGeorg M. Lauer
Georg M. Lauer

2 December 2022 in Cancer Research
Verified
Journal Article
Open access
PDF file
JCJordi Camps
Jordi Camps
FNFloriane Noël
Floriane Noël
RLRobin Liechti
Robin Liechti
LMLucile Massenet-Regad
Lucile Massenet-Regad
SRSidwell Rigade
Sidwell Rigade
VSVassili Soumelis
Vassili Soumelis
The development of single-cell RNA sequencing (scRNA-seq) technologies has greatly contributed to deciphering the tumor microenvironment (TME). An enormous amount of independent scRNA-seq studies have been published representing a valuable resource that provides opportunities for meta-analysis studies. However, the massive amount of biological information, the marked heterogeneity and variability between studies, and the technical challenges in processing heterogeneous datasets create major bottlenecks for the full exploitation of scRNA-seq data. We have developed IMMUcan scDB (https://immucanscdb.vital-it.ch), a fully integrated scRNA-seq database exclusively dedicated to human cancer and accessible to nonspecialists. IMMUcan scDB encompasses 144 datasets on 56 different cancer types, annotated in 50 fields containing precise clinical, technological, and biological information. A data processing pipeline was developed and organized in four steps: (i) data collection; (ii) data processing (quality control and sample integration); (iii) supervised cell annotation with a cell ontology classifier of the TME; and (iv) interface to analyze TME in a cancer type–specific or global manner. This framework was used to explore datasets across tumor locations in a gene-centric (CXCL13) and cell-centric (B cells) manner as well as to conduct meta-analysis studies such as ranking immune cell types and genes correlated to malignant transformation. This integrated, freely accessible, and user-friendly resource represents an unprecedented level of detailed annotation, offering vast possibilities for downstream exploitation of human cancer scRNA-seq data for discovery and validation studies. Significance: The IMMUcan scDB database is an accessible supportive tool to analyze and decipher tumor-associated single-cell RNA sequencing data, allowing researchers to maximally use this data to provide new insights into cancer biology.

13 April 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
CHCaroline Hoffmann
Caroline Hoffmann
FNFloriane Noel
Floriane Noel
MGMaximilien Grandclaudon
Maximilien Grandclaudon
LMLucile Massenet-Regad
Lucile Massenet-Regad
PMPaula Michea
Paula Michea
VSVassili Soumelis
Vassili Soumelis
Dendritic cells (DC) are traditionally classified according to their ontogeny and their ability to induce T cell response to antigens, however, the phenotypic and functional state of these cells in cancer does not necessarily align to the conventional categories. Here we show, by using 16 different stimuli in vitro that activated DCs in human blood are phenotypically and functionally dichotomous, and pure cultures of type 2 conventional dendritic cells acquire these states (termed Secretory and Helper) upon appropriate stimuli. PD-L1highICOSLlow Secretory DCs produce large amounts of inflammatory cytokines and chemokines but induce very low levels of T helper (Th) cytokines following co-culturing with T cells. Conversely, PD-L1lowICOSLhigh Helper DCs produce low levels of secreted factors but induce high levels and a broad range of Th cytokines. Secretory DCs bear a single-cell transcriptomic signature indicative of mature migratory LAMP3+ DCs associated with cancer and inflammation. Secretory DCs are linked to good prognosis in head and neck squamous cell carcinoma, and to response to checkpoint blockade in Melanoma. Hence, the functional dichotomy of DCs we describe has both fundamental and translational implications in inflammation and immunotherapy.

1 March 2024 in Bioinformatics
Verified
Journal Article
Open access
PDF file
LMLucile Massenet-Regad
Lucile Massenet-Regad
VSVassili Soumelis
Vassili Soumelis
Summary: Several methods have been developed in the past years to infer cell–cell communication networks from transcriptomic data based on ligand and receptor expression. Among them, ICELLNET is one of the few approaches to consider the multiple subunits of ligands and receptors complexes to infer and quantify cell communication. In here, we present a major update of ICELLNET. As compared to its original implementation, we (i) drastically expanded the ICELLNET ligand-receptor database from 380 to 1669 biologically curated interactions, (ii) integrated important families of communication molecules involved in immune crosstalk, cell adhesion, and Wnt pathway, (iii) optimized ICELLNET framework for single-cell RNA sequencing data analyses, (iv) provided new visualizations of cell–cell communication results to facilitate prioritization and biological interpretation. This update will broaden the use of ICELLNET by the scientific community in different biological fields. Availability and implementation: ICELLNET package is implemented in R. Source code, documentation and tutorials are available on GitHub (https://github.com/soumelis-lab/ICELLNET).